Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT01825564 · ClinicalTrials.gov registry record

Comparison of RightSpot pH Indicator & RightLevel pH Detector With X-Ray Verification for FT or G-Tube Placement

A clinical trial, sponsored by St. Louis University.

Terminated
Registry status
11
Enrollment target

NCT01825564: Clinical Trial study, sponsored by St. Louis University.

NCT01825564 is a clinical trial that was terminated before completion, run by St. Louis University. The registered enrollment target is 11 participants. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT01825564 was terminated before completion, sponsored by St. Louis University.

TERMINATED
Registry status
11 participants
Enrollment target

Study Summary

Replacing a G tube and placing feeding tubes is standard in the Emergency Department (ED) and ICU, respectively. However placement requires a chest or abdominal x-ray to confirm correct position. The investigators are testing the accuracy of the FDA approved devices RightSpot pH Indicator \& RightLevel pH Detector in determining correct position based upon pH which will then be correlated with the standard of care x-ray.

Primary Outcome

The pH measurement obtained will be used to determine correct placement of the gastric or feeding tube as compared to the gold standard method of X-ray following gastrograffin administration

Trial Details

FieldValue
Enrollment Target 11 participants
Start Date 2013-03-14
Est. Completion 2016-05-25
St. Louis University

107 total trials

Why NCT01825564 stopped before completion

NCT01825564 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 11 participants, a relatively small participant target.

The record links to 0 conditions, and to 0 interventions.

NCT01825564 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT01825564 about?

NCT01825564 is a clinical study titled "Comparison of RightSpot pH Indicator & RightLevel pH Detector With X-Ray Verification for FT or G-Tube Placement". Replacing a G tube and placing feeding tubes is standard in the Emergency Department (ED) and ICU, respectively. However placement requires a chest or abdominal x-ray to confirm correct position. The investigators are testing the accuracy of the FDA approved devices RightSpot pH Indicator \& RightLe...

What is the current status of trial NCT01825564?

This trial is currently terminated. The enrollment target is 11 participants. The study started on 2013-03-14. Estimated completion is 2016-05-25.

Who is sponsoring clinical trial NCT01825564?

This trial is sponsored by St. Louis University, which has 107 total clinical trials registered on ClinicalTrials.gov.

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT03114462 · 11 participants · Phase 1

    Trial of Stereotactic HYpofractionateD RadioAblative (HYDRA) Treatment of Laryngeal Cancer

  • NCT06039709 · 11 participants · Phase 1

    Sonodynamic Therapy in Patients With Recurrent GBM

  • NCT06425380 · 11 participants · NA

    Pilot Open-Label Trial of Resistant Potato Starch in Patients With Cirrhosis and Overt Hepatic Encephalopathy

  • NCT06472661 · 11 participants · Early Phase 1

    FUSA With Intratumoral PolyICLC in Regionally Advanced Resectable Melanoma

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT01825564, the US trial registry maintained by the National Library of Medicine. NCT01825564 (small enrollment · none site footprint · terminated) retrieved and formatted by PlainTrial, see methodology.